Dopamine Beta Hydroxylase

  1. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity
  2. DOPAMINEย BETAโ€“HYDROXYLASEย deficiency. A genetic disorder of cardiovascular regulation.
  3. DOPAMINEย BETAโ€“HYDROXYLASEย of adrenal chromaffin granules: structure and function
  4. DOPAMINEย BETAโ€“HYDROXYLASEย deficiency
  5. Reducedย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in Alzheimerโ€™s disease
  6. DOPAMINEย BETAโ€“HYDROXYLASEย : biochemistry and molecular biology.
  7. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosineย HYDROXYLASEย andย DOPAMINEโ€BETAโ€HYDROXYLASE
  8. DOPAMINEโ€“BETAโ€“HYDROXYLASE
  9. DOPAMINEย BETAโ€HYDROXYLASEย and its genetic variants in human health and disease
  10. Association of theย DOPAMINEย BETAย HYDROXYLASEย gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study
  11. Localization of the humanย DOPAMINEย BETAย HYDROXYLASEย (DBH) gene to chromosome 9q34
  12. Endogenous restoration of noradrenaline by precursor therapy inย DOPAMINEโ€“BETAโ€“HYDROXYLASEย deficiency
  13. Clinical presentation and longโ€term followโ€up ofย DOPAMINEย BETAย HYDROXYLASEย deficiency
  14. Congenitalย DOPAMINEโ€“BETAโ€“HYDROXYLASEย deficiency: A novel orthostatic syndrome
  15. The primary structure of humanย DOPAMINEโ€BETAโ€HYDROXYLASEย : insights into the relationship between the soluble and the membraneโ€bound forms of the enzyme.
  16. Kinetic and spectroscopic studies of the interaction of copper withย DOPAMINEย BETAโ€“HYDROXYLASEย .
  17. Tyrosineย HYDROXYLASEย , but notย DOPAMINEย BETAโ€“HYDROXYLASEย , is increased in rat frontal cortex after traumatic brain injury
  18. A genetic association study of migraine withย DOPAMINEย receptor 4,ย DOPAMINEย transporter andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย genes
  19. Inheritance of very low serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity.
  20. DOPAMINEย BETAโ€“HYDROXYLASEย gene modulates individualsโ€™ empathic ability
  21. Plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย activity in psychotic and non-psychotic post-traumatic stress disorder
  22. Mechanism-based inactivation ofย DOPAMINE.ย BETA.-HYDROXYLASEย by p-cresol and related alkylphenols
  23. Attention deficit hyperactivity disorder and the gene forย DOPAMINEย BETAโ€“HYDROXYLASE
  24. Regulation ofย DOPAMINEย BETAโ€“HYDROXYLASEย in rat adrenal glands.
  25. Association between a 19 bp deletion polymorphism at theย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) locus and migraine with aura
  26. Neuron-specific expression of the humanย DOPAMINEย BETAโ€“HYDROXYLASEย gene requires both the cAMP-response element and a silencer region.
  27. Effects of reserpine on activities and amounts of tyrosineย HYDROXYLASEย andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in catecholamine neuronal systems in rat brain.
  28. Multisubstrate inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย . 2. Structure-activity relationships at the phenethylamine binding site
  29. DOPAMINEย BETAโ€HYDROXYLASEย (DBH) activity and โ€1021C/T polymorphism of DBH gene in combatโ€related postโ€traumatic stress disorder
  30. Linkage of a gene regulatingย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and the ABO blood group locus.
  31. Ultrastructural demonstration of noradrenergic synapses in the rat central nervous system byย DOPAMINEโ€“BETAโ€“HYDROXYLASEย immunocytochemistry.
  32. Effects of acupuncture on serum cortisol level andย DOPAMINEย BETAโ€“HYDROXYLASEย activity in normal Chinese
  33. Characterization of a carbon monoxide complex of reducedย DOPAMINEย BETAโ€“HYDROXYLASEย . Evidence for inequivalence of the Cu (I) centers.
  34. Genotype-independent decrease in plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย activity in Alzheimerโ€™s disease
  35. Humanย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure
  36. Theย DOPAMINEย BETAโ€HYDROXYLASEย inhibitor nepicastat increasesย DOPAMINEย release and potentiates psychostimulantโ€inducedย DOPAMINEย release in the prefrontal cortex
  37. Isolation and reconstitution of the membrane-bound form ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  38. โ€ฆ neuronal perikarya and fibres in the brain of a teleost, Gasterosteus aculeatus L. comparison with tyrosineย HYDROXYLASEย -andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย โ€ฆ
  39. Functional and high level expression of humanย DOPAMINEย BETAโ€“HYDROXYLASEย in transgenic mice.
  40. In vivo cell type-specific CRISPR knockdown ofย DOPAMINEย BETAย HYDROXYLASEย reduces locus coeruleus evoked wakefulness
  41. DOPAMINEโ€“BETAโ€“HYDROXYLASEย in the cerebrospinal fluid of psychiatric patients.
  42. Soluble and membrane-bound forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย are encoded by the same mRNA.
  43. Functional model ofย DOPAMINE.ย BETA.-HYDROXYLASEย . quantitative ligand hydroxylation at the benzylic position of a copper complex by dioxygen
  44. DOPAMINEย BETAย HYDROXYLASEย genotype identifies individuals less susceptible to bias in computer-assisted decision making
  45. Polymorphisms and low plasma activity ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in ADHD children
  46. Lowย DOPAMINEโ€“BETAโ€“HYDROXYLASEย : a biological sequela of abuse and neglect?
  47. Development ofย DOPAMINEโ€BETAย HYDROXYLASEย โ€”positive fiber innervation of the rat hippocampus
  48. Carbonmonoxyย DOPAMINEย BETAโ€“HYDROXYLASEย . Structural characterization by Fourier transform infrared, fluorescence, and x-ray absorption spectroscopy.
  49. DOPAMINEย BETAโ€HYDROXYLASEย (DBH) gene and schizophrenia phenotypic variability: A genetic association study
  50. Selective depletion of cortical noradrenaline by anti-DOPAMINEย BETAโ€“HYDROXYLASEย โ€“saporin impairs attentional function and enhances the effects of guanfacine in the rat
  51. The expression of dopa decarboxylase andย DOPAMINEย BETAย HYDROXYLASEย and their responding to bacterial challenge during the ontogenesis of scallop Chlamys farreri
  52. DOPAMINEย BETAโ€“HYDROXYLASEย participate in the immunoendocrine responses of hypothermal stressed white shrimp, Litopenaeus vannamei
  53. Regional brain abnormalities in norepinephrine uptake andย DOPAMINEย BETAโ€“HYDROXYLASEย activity in the genetically epilepsy-prone rat.
  54. Positive association betweenโˆ’ 1021TT genotype ofย DOPAMINEย BETAย HYDROXYLASEย gene and progressive behavior of injection heroin users
  55. Design and kinetic characterization of multisubstrate inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  56. Decreasedย DOPAMINEย BETAโ€“HYDROXYLASEย activity in unipolar geriatric delusional depression
  57. DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) and homovanillic acid (HVA) in autistic children
  58. Cell-specific expression from the humanย DOPAMINEย BETAโ€“HYDROXYLASEย promoter in transgenic mice is controlled via a combination of positive and negative regulatory โ€ฆ
  59. โ€ฆ postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline fromย DOPAMINEย because of a deficiency ofย DOPAMINEย BETAย HYDROXYLASE
  60. Analysis ofย DOPAMINEย BETAย HYDROXYLASEย gene polymorphisms in migraine
  61. Association ofย DOPAMINEย BETAโ€“HYDROXYLASEย polymorphisms with alzheimerโ€™s disease, Parkinsonโ€™s disease and schizophrenia: evidence based on currently available โ€ฆ
  62. Copper K-extended x-ray absorption fine structure studies of oxidized and reducedย DOPAMINEย BETAโ€“HYDROXYLASEย . Confirmation of a sulfur ligand to copper (I) in โ€ฆ
  63. Electron spin-echo studies of the copper (II) binding sites inย DOPAMINE.ย BETA.-HYDROXYLASE
  64. Minor physical anomalies and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in hyperactive boys
  65. DOPAMINE.ย BETA.-HYDROXYLASEย : activity and inhibition in the presence of.ย BETA.-substituted phenethylamines
  66. Serumย DOPAMINEโ€”BETAโ€”HYDROXYLASEย during development of immobilizationโ€”induced hypertension
  67. โ€ฆ mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats followingย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibition.
  68. Cardiovascular effects of a new potentย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitor in spontaneously hypertensive rats.
  69. DOPAMINEโ€“BETAย HYDROXYLASEย polymorphism and cocaine addiction
  70. Selective inhibition ofย DOPAMINEโ€BETAโ€HYDROXYLASEย enhancesย DOPAMINEย release from noradrenergic terminals in the medial prefrontal cortex
  71. Association betweenย DOPAMINEย BETAย HYDROXYLASEย rs5320 polymorphism and smoking behaviour in elderly Japanese
  72. Plasma noradrenaline andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย during human sexual activity
  73. The copper sites ofย DOPAMINE.ย BETA.-HYDROXYLASEย : an x-ray absorption spectroscopic study
  74. Release of catecholamines andย DOPAMINEย BETAโ€HYDROXYLASEย from the perfused adrenal gland of the cat.
  75. Inactivation ofย DOPAMINE.ย BETA.-HYDROXYLASEย by p-cresol: isolation and characterization of covalently modified active site peptides
  76. Human plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย . Purification and properties.
  77. Involvement ofย DOPAMINEย BETAโ€“HYDROXYLASEย in the neuroendocrine-immune regulatory network of white shrimp, Litopenaeus vannamei
  78. The mechanism of inactivation ofย DOPAMINEย BETAโ€“HYDROXYLASEย by hydrazines.
  79. Suppression of ethanol intake following administration ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors in rats.
  80. Antihypertensive effect of aย DOPAMINEย BETAย HYDROXYLASEย inhibitor, bupicomide: a comparison with hydralazine
  81. Plasma norepinephrine concentration and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in patients with congestive heart failure.
  82. Multisubstrate inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย . 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione
  83. Plasma adrenaline and noradrenaline concentrations andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in myocardial infarction with and without cardiogenic shock.
  84. โ€ฆ catecholaminergic modulation of visual attention: differential effects of catechol-O-methyltransferase andย DOPAMINEย BETAโ€“HYDROXYLASEย genes on visual โ€ฆ
  85. Analysis of theย DOPAMINEย BETAย HYDROXYLASEย gene in Gilles de la Tourette syndrome
  86. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells inย DOPAMINEย BETAย HYDROXYLASEย knockout mice
  87. Reflex control of sympathetic nerve activity inย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency.
  88. DOPAMINEย BETAโ€“HYDROXYLASEย activity in cerebrospinal fluid of parkinsonian patients
  89. Mechanism of biosynthesis of soluble and membrane-bound forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย in PC12 pheochromocytoma cells.
  90. Bovineย DOPAMINEย BETAโ€“HYDROXYLASEย cDNA. Complete coding sequence and expression in mammalian cells with vaccinia virus vector.
  91. Changes ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during ontogenesis in healthy subjects and in an experimental model (rats)
  92. Human pheochromocytomaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย : purification and molecular parameters of the tetramer
  93. Asymmetric sulfoxidation byย DOPAMINE.ย BETA.-HYDROXYLASEย , an oxygenase heretofore considered specific for methylene hydroxylation
  94. The cAMP-dependent protein kinase regulates transcription of theย DOPAMINEย BETAโ€“HYDROXYLASEย gene
  95. โ€ฆ noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย โ€ฆ
  96. โ€ฆ : linkage analysis excludes a role for the genes coding forย DOPAMINEย D1, D2, D3, D4, D5 receptors,ย DOPAMINEย BETAย HYDROXYLASEย , tyrosinase, and tyrosineย HYDROXYLASE
  97. Preparation and Characterization of Half-Apoย DOPAMINE-.ย BETA.-HYDROXYLASEย by Selective Removal of CuA. Identification of a Sulfur Ligand at the Dioxygen Binding โ€ฆ
  98. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity: Clinical applications in child psychiatry
  99. Human serumย DOPAMINEย BETAโ€“HYDROXYLASEย : correlation of enzymatic activity with immunoreactive protein in genetically defined samples.
  100. Deduction of kinetic mechanism in multisubstrate enzyme reactions from tritium isotope effects. Application toย DOPAMINEย BETAโ€“HYDROXYLASEย .
  101. Subunit exchange between membranous and soluble forms of bovineย DOPAMINEย BETAโ€“HYDROXYLASEย .
  102. Impaired temporal resolution of visual attention andย DOPAMINEย BETAย HYDROXYLASEย genotype in attention-deficit/hyperactivity disorder
  103. Association betweenย DOPAMINEย BETAย HYDROXYLASEย gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder
  104. Mechanism-based inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย containing acetylenic or cyclopropyl groups
  105. Measurement of humanย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in serum by homologous radioimmunoassay.
  106. Alternate substrates ofย DOPAMINEย BETAโ€“HYDROXYLASEย . I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
  107. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in affective disorders
  108. DOPAMINEย BETAย HYDROXYLASEย (DBH) plasma activity in childhood mental disorders
  109. Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates forย DOPAMINE.ย BETA.-HYDROXYLASE
  110. Increased ganglionic tyrosineย HYDROXYLASEย andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activities following preganglionic nerve stimulation: role of nicotine receptors.
  111. The pH-dependent subunit dissociation and catalytic activity of bovineย DOPAMINEย BETAโ€“HYDROXYLASEย .
  112. The role of norepinephrine in the function of the area postrema. I. Immunofluorescent localization ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and electron microscopy
  113. Partial characterization of a naturally occurring inhibitor ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  114. Decreased serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in hyperthyroidism
  115. The activity ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and methionine-activating enzyme in blood of schizophrenic patients.
  116. โ€ฆ -substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย . 4. Structure-activity โ€ฆ
  117. Linkage disequilibrium analysis of theย DOPAMINEย BETAโ€“HYDROXYLASEย gene in persistent attention deficit hyperactivity disorder
  118. Unsaturated heterocyclic amines as potent time-dependent inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  119. Analysis of polymorphisms in theย DOPAMINEย BETAย HYDROXYLASEย gene: association with attention deficit hyperactivity disorder in Indian children
  120. Platelet monoamine oxidase, plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and attention in aโ€ biochemical high riskโ€ sample.
  121. Sleep patterns in congenitalย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency
  122. Effects of disulfiram andย DOPAMINEย BETAโ€“HYDROXYLASEย knockout on cocaine-induced seizures
  123. Complete Assignment of Disulfide Bonds in Bovineย DOPAMINE.ย BETA.-HYDROXYLASE
  124. 3-Phenylpropenes as mechanism-based inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย : evidence for a radical mechanism
  125. ABO B gene is associated with introversion personality tendancies through linkage withย DOPAMINEย BETAย HYDROXYLASEย gene
  126. DOPAMINEโ€“BETAโ€“HYDROXYLASEย in behaviorally disturbed youth: Relationship between teacher and parent ratings
  127. Release of norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
  128. Purified cytochrome b561 catalyzes transmembrane electron transfer forย DOPAMINEย BETAโ€“HYDROXYLASEย and peptidyl glycine alpha-amidating monooxygenase โ€ฆ
  129. Lack of significant association betweenโˆ’ 1021Cโ†’ T polymorphism in theย DOPAMINEย BETAย HYDROXYLASEย gene and attention deficit hyperactivity disorder
  130. Plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย : rapid diagnostic test for recurrent hereditary polyserositis
  131. The distribution ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย , neuropeptide Y and galanin in locus coeruleus neurons.
  132. Identification and functional characterisation of a novelย DOPAMINEย BETAย HYDROXYLASEย gene variant associated with attention deficit hyperactivity disorder
  133. Aย DOPAMINEย BETAย HYDROXYLASEย from Chlamys farreri and its induced mRNA expression in the haemocytes after LPS stimulation
  134. Changes in plasma catecholamines andย DOPAMINEย BETAโ€“HYDROXYLASEย after corrective surgery for coarctation of the aorta.
  135. .ย BETA.-Substituted phenethylamines as high-affinity mechanism-based inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  136. Canย DOPAMINEย BETAโ€HYDROXYLASEย Levels Predict Adverse Reactions to Disulfiram?
  137. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and catecholamine levels in the plasma of patients with renal failure
  138. Plasma norepinephrine, epinephrine, andย DOPAMINEย BETAโ€“HYDROXYLASEย activity during exercise in man.
  139. Primary amino acid sequence of bovineย DOPAMINEย BETAโ€“HYDROXYLASEย .
  140. Association betweenย DOPAMINEย BETAโ€“HYDROXYLASEย 19-bp insertion/deletion polymorphism and major depressive disorder
  141. A bifunctional genetic regulatory element of the ratย DOPAMINEย BETAโ€“HYDROXYLASEย gene influences cell type specificity and second messenger-mediated โ€ฆ
  142. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension inย DOPAMINEโ€“BETAโ€“HYDROXYLASEย deficiency
  143. โ€ฆ to the anxiety-modulating effects of offspring contact is associated with innate anxiety and brainstem levels ofย DOPAMINEย BETAโ€“HYDROXYLASEย in female laboratory rats
  144. Determination of serumย DOPAMINE-.ย BETA.-HYDROXYLASEย activity by reverse-phase liquid chromatography with column switching
  145. The meaning ofย DOPAMINEย BETAโ€“HYDROXYLASEย in essential hypertension.
  146. Elevated plasmaย DOPAMINEย BETAย HYDROXYLASEย activity in rats with neurogenic hypertension
  147. Exocytotic release of catecholamines andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย from the perfused adrenal gland of the rabbit and cat.
  148. DOPAMINEย BETAโ€“HYDROXYLASEย inhibition in a patient with Wilsonโ€™s disease and manic symptoms.
  149. The effect of some dithiocarbamic acids onย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and catecholamines level in ratโ€™s brain.
  150. Effect of acute volume alterations on norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in normotensive and hypertensive subjects.
  151. DOPAMINEโ€“BETAโ€“HYDROXYLASEย : an index of adrenergic function in hypertensive patients
  152. Association ofย DOPAMINEย BETAโ€“HYDROXYLASEย polymorphism with attention deficit hyperactivity disorder in children
  153. Maternal and fetal plasma renin andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activities in toxemic pregnancy.
  154. Nerve stimulation-meditated overflow of norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย . III. Effects of norepinephrine depletion on the alpha presynaptic regulation โ€ฆ
  155. Association of aย DOPAMINEย BETAโ€“HYDROXYLASEย gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction
  156. Inhibition ofย DOPAMINE.ย BETA.-HYDROXYLASEย by 5-phenoxymethyl-2-oxazolidinethiones
  157. Localization ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย -like immunoreactivity in the superior olivary complex of the rat.
  158. DOPAMINEโ€“BETAโ€“HYDROXYLASEย 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
  159. An acetylenic mechanism-based inhibitor ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  160. Plasma noradrenaline andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย during sexual activity
  161. Mosaic deletion 11p13 in a child withย DOPAMINEย BETAโ€HYDROXYLASEย deficiencyโ€”Case report and review of the literature
  162. โ€ฆ reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย . Implications for treatment โ€ฆ
  163. Active site ofย DOPAMINE.ย BETA.-HYDROXYLASEย . Comparison of enzyme derivatives containing four and eight copper atoms per tetramer using potentiometry and EPR โ€ฆ
  164. Noradrenergic innervation of the human adrenal cortex as revealed byย DOPAMINEโ€“BETAโ€“HYDROXYLASEย immunohistochemistry.
  165. A Preliminary Study of DBH (Encodingย DOPAMINEย BETAโ€“HYDROXYLASEย ) Genetic Variation and Neural Correlates of Emotional and Motivational โ€ฆ
  166. DOPAMINEย BETAโ€“HYDROXYLASEย . Inactivation by a suicide substrate.
  167. โ€ฆ in relation to variation in three genes involved inย DOPAMINEย metabolism: Catechol-O-methyltransferase (COMT),ย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) and monoamine โ€ฆ
  168. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in oral contraceptive hypertension.
  169. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in acute stroke.
  170. Lack of correlation of plasma norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in hypertensive and normotensive subjects.
  171. Inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย . 3. Some 1-(pyridylmethyl) imidazole-2-thiones
  172. Anti-DOPAMINEย BETAโ€“HYDROXYLASEย immunotoxin-induced sympathectomy in adult rats.
  173. CONCOMITANT ELEVATION OF TYROSINEย HYDROXYLASEย ANDย DOPAMINEย BETAโ€HYDROXYLASEย BY CYCLIC AMP IN CULTURED MOUSE โ€ฆ
  174. Segregation and linkage studies of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase โ€ฆ
  175. Sulfation and constitutive secretion ofย DOPAMINEย BETAโ€“HYDROXYLASEย from rat pheochromocytoma (PC12) cells.
  176. Serumย DOPAMINEย BETAโ€“HYDROXYLASEย activity in menstrual migraine.
  177. Suppression of voluntary ingestion of morphine by inhibition ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  178. Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for ratย DOPAMINEย BETAโ€“HYDROXYLASEย .
  179. The sympathetic skin response in peripheral autonomic failureโ€”evaluation in pure autonomic failure, pure cholinergic dysautonomia andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย โ€ฆ
  180. ABO group B is associated with personality traits through linkage disequilibrium with low activityย DOPAMINEย BETAย HYDROXYLASE
  181. DOPAMINEย BETAโ€“HYDROXYLASEย and its role in regulating the growth and larval metamorphosis in Sinonovacula constricta
  182. Theย DOPAMINEย BETAโ€“HYDROXYLASEย gene polymorphism rs1611114 is associated with schizophrenia in the Chinese Zhuang but not Chinese Han population
  183. Pharmacological action of FD-008, a newย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitor. I. Effects on blood pressure in rats and dogs.
  184. Effect of Hypophysectomy on Serumย DOPAMINEโ€”BETAโ€”HYDROXYLASEย Activity in Rat
  185. Kinetic characterization of rat serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย using a simplified radioenzymatic assay
  186. Family studies of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย thermal stability.
  187. Isomer specific kinetics ofย DOPAMINEย BETAโ€“HYDROXYLASEย and arylsulfatase towards catecholamine sulfates.
  188. In vivo biosynthesis of two subunit forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย in rat brain
  189. Expression ofย DOPAMINEย BETAโ€“HYDROXYLASEย in Drosophila Schneider 2 cells. Evidence for a mechanism of membrane binding other than uncleaved signal peptide
  190. PLASMAย DOPAMINEโ€BETAโ€HYDROXYLASEย ACTIVITY IN PHAEOCHROMOCYTOMA
  191. Genetic analysis of serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in rats
  192. Tissue and plasma catecholamines andย DOPAMINEย BETAโ€HYDROXYLASEย activity of various animal species after neurogenic sympathetic stimulation.
  193. Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  194. Bovineย DOPAMINE.ย BETA.-HYDROXYLASEย , primary structure determined by cDNA cloning and amino acid sequencing
  195. Isotope effects in the hydroxylation of phenylethylamine byย DOPAMINE.ย BETA.-HYDROXYLASE
  196. Effect of an inhibitor ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย on the acquisition and retention of four different avoidance tasks in mice
  197. Distribution ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย -like immunoreactive fibers in the rat cerebellar cortex during ontogeny
  198. On-line synthesis utilizing immobilized enzyme reactors based upon immobilizedย DOPAMINEย BETAโ€“HYDROXYLASE
  199. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and blood pressure.
  200. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in depressed patients and controls
  201. Clonidine reverses the amnesia induced byย DOPAMINEย BETAย HYDROXYLASEย inhibition
  202. Possible increase ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study
  203. Effect ofย BETA-adrenergic blockade on circulating catecholamines andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during exercise in normal subjects
  204. 24-hourย DOPAMINEโ€“BETAโ€“HYDROXYLASEย pattern: A possible biological index of manic-depression
  205. DOPAMINEย BETAย HYDROXYLASEย gene polymorphism and Parkinsonโ€™s disease
  206. Regulation of the multiple forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย by nerve growth factor, dexamethasone, and dibutyryl cyclic AMP in the PC12 pheochromocytoma cell โ€ฆ
  207. DOPAMINEโ€“BETAโ€“HYDROXYLASEย -positive nerves in normal and transplanted pancreatic tissue in the anterior eye-chamber of rats
  208. Neuropeptide Y plasma levels and serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in MS patients with and without abnormal cardiovascular reflexes.
  209. A genetic study of plasmaย DOPAMINEย BETAย HYDROXYLASEย activity in man
  210. The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in the rat.
  211. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in identical twins discordant for schizophrenia
  212. โ€ฆ characterization of bipolar affective disorders: a focus on tardive dyskinesia and soft neurological signs in relation to serumย DOPAMINEย BETAย HYDROXYLASEย activity
  213. Activity of the enzymesย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and phenylethanolamine-N-methyltransferase in discrete brain regions of the copper-zinc deficient rat following โ€ฆ
  214. Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) activities in the โ€ฆ
  215. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) activity during the menstrual cycle
  216. DOPAMINEโ€“BETAโ€“HYDROXYLASEย and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients
  217. Glycosylation and membrane insertion of newly synthesized ratย DOPAMINEย BETAโ€“HYDROXYLASEย in a cell-free system without signal cleavage.
  218. Catecholamine metabolites affected by the copper-dependent enzymeย DOPAMINEโ€“BETAโ€“HYDROXYLASEย provide sensitive biomarkers for early diagnosis of menkes โ€ฆ
  219. Effect ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibition on cerebral vasospasm in the cat
  220. Serumย DOPAMINEย BETAโ€“HYDROXYLASEย activity following subarachnoid hemorrhage in man.
  221. Highly effective mechanism-based inactivation ofย DOPAMINE.ย BETA.-HYDROXYLASEย by a novel ketene thioacetal
  222. Active site labeling ofย DOPAMINEย BETAโ€“HYDROXYLASEย by two mechanism-based inhibitors: 6-hydroxybenzofuran and phenylhydrazine.
  223. Plasma renin and serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย during orthostatic hypotension in quadriplegic man.
  224. Purification and properties of human serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  225. Levels ofย DOPAMINEย BETAย HYDROXYLASEย immunoreactivity in the preoptic hypothalamus of the ovariectomised ewe following injection of oestrogen: evidence for โ€ฆ
  226. Association ofย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) polymorphisms with susceptibility to Parkinsonโ€™s disease
  227. Nerve fibers immunoreactive to calcitonin gene-related peptide, substance P, neuropeptide Y, andย DOPAMINEย BETAโ€“HYDROXYLASEย in innervated and denervated oral โ€ฆ
  228. The relationship between serotonin,ย DOPAMINEย BETAย HYDROXYLASEย and GABA immunoreactive inputs and spinal preganglionic neurones projecting to the major pelvic โ€ฆ
  229. Heart rate variation and serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in workers exposed to vibration
  230. Proportions of renal and splenic postganglionic sympathetic populations containing galanin andย DOPAMINEย BETAย HYDROXYLASE
  231. Synthesis of chromogranins andย DOPAMINEย BETAโ€“HYDROXYLASEย by perfused bovine adrenal glands.
  232. Hypertensive crises in quadriplegic patients. Changes in cardiac output, blood volume, serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity, and arterial prostaglandin PGE2.
  233. Brainย DOPAMINEย BETAย HYDROXYLASEย activity: response to stress, tyrosineย HYDROXYLASEย inhibition, hypophysectomy and ACTH administration
  234. The in situ kinetics ofย DOPAMINEย BETAโ€“HYDROXYLASEย in bovine adrenomedullary chromaffin cells. Intravesicular compartmentation reduces apparent affinity for the โ€ฆ
  235. Human plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย : variation in thermal stability
  236. The molecular shape ofย DOPAMINEย BETAโ€“HYDROXYLASEย from chromaffin granules of bovine adrenal medulla.
  237. Purification and characterization of avianย DOPAMINE.ย BETA.-HYDROXYLASE
  238. The association of C789A polymorphism in theย DOPAMINEย BETAโ€“HYDROXYLASEย gene (DBH) and aggressive behaviour in dogs
  239. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in depressed patients and the effect of electroconvulsive shock treatment
  240. A genetic study of plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย in affective disorder.
  241. DOPAMINEย BETAย HYDROXYLASEย : an enzyme with therapeutic potential to combat neural and cardiovascular diseases
  242. Sensation seeking, exercise, andย DOPAMINEย BETAย HYDROXYLASE
  243. Changes in platelet monoamine oxidase and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activities in lithium-treated bipolar patients
  244. Inactivation ofย DOPAMINE.ย BETA.-HYDROXYLASEย by.ย BETA.-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide
  245. Mechanism-based inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASEย : inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene
  246. Release of norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine โ€ฆ
  247. Alternate substrates ofย DOPAMINEย BETAโ€“HYDROXYLASEย . III. Stoichiometry of the inactivation reaction with benzyl cyanides and spectroscopic investigations.
  248. Association Betweenย DOPAMINEย BETAโ€“HYDROXYLASEย Gene Polymorphisms and Attention-Deficit Hyperactivity Disorder in Korean Children
  249. Effect of variations in adrenocortical function onย DOPAMINEย BETAโ€“HYDROXYLASEย and norepinephrine in the brain of the rat.
  250. Role of copper and catalytic mechanism in the copper monooxygenase,ย DOPAMINEย BETAโ€“HYDROXYLASEย (Dย BETAย H).
  251. Distribution ofย DOPAMINEย BETAโ€“HYDROXYLASEย and neuropeptide Y-immunoreactive nerves in healthy equine lungs.
  252. Distribution ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย โ€”like immunoreactivity in the rat pineal organ
  253. A single nucleotide polymorphism inย DOPAMINEย BETAย HYDROXYLASEย (rs6271 (C> T)) is over-represented in inflammatory bowel disease patients and reduces โ€ฆ
  254. Variants ofย DOPAMINEย BETAย HYDROXYLASEย gene moderate atomoxetine response in children with attention-deficit/hyperactivity disorder
  255. Association of functionalย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers
  256. Bovine membranousย DOPAMINEย BETAโ€“HYDROXYLASEย is not anchored via covalently attached phosphatidylinositol.
  257. DOPAMINEย BETAโ€“HYDROXYLASEย activity in the cat carotid body
  258. Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activities.
  259. Pharmacological action of FD-008, a newย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitor.
  260. Adenosine 5โ€ฒ-diphosphate-dependent subunit dissociation of bovineย DOPAMINEย BETAโ€“HYDROXYLASEย .
  261. Association betweenย DOPAMINEย BETAย HYDROXYLASEย gene polymorphism and age at onset in male schizophrenia
  262. The influence ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with โ€ฆ
  263. Generation of two noradrenergic-specificย DOPAMINEโ€“BETAโ€“HYDROXYLASEย -FLPo knock-in mice using CRISPR/Cas9-Mediated targeting in embryonic stem cells
  264. Some characteristics of amnesia induced by FLA-63 an inhibitor ofย DOPAMINEย BETAย HYDROXYLASE
  265. Effects of various inhibitors of tyrosineย HYDROXYLASEย andย DOPAMINEย BETAโ€“HYDROXYLASEย on rat self-stimulation after reserpine treatment
  266. Effects of aging on the activity of hypothalamicย DOPAMINEโ€“BETAโ€“HYDROXYLASEย during various stages of the estrous cycle in C57BL/6 mice
  267. Relationship to survival of catecholamine levels andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in experimental haemorrhagic shock.
  268. Circulating catecholamines, plasma renin andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity with postural stress
  269. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in women occupationally exposed to carbon disulphide
  270. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in diagnostic subgroups of depressed patients and in relation to their personality characteristics
  271. Serumย DOPAMINEย BETAโ€“HYDROXYLASEย activity in essential hypertension.
  272. Alternate substrates ofย DOPAMINEย BETAโ€“HYDROXYLASEย . II. Inhibition by benzyl cyanides and reactivation of inhibited enzyme.
  273. Influence of age, sex and hypoxia on plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in the rat.
  274. Concentration ofย DOPAMINEย in plasma, activity ofย DOPAMINEย BETAโ€“HYDROXYLASEย in serum and urinary excretion of free catecholamines and vanillylmandelic acid in โ€ฆ
  275. Immunocytochemical colocalizations of insulin, aromatic L-amino acid decarboxylase,ย DOPAMINEย BETAโ€“HYDROXYLASEย , S-100 protein and chromogranin A in B-cells of the โ€ฆ
  276. The study of levels of norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in patients with pregnancy-induced hypertension.
  277. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension inย DOPAMINEโ€“BETAโ€“HYDROXYLASEย deficiency.
  278. DOPAMINEโ€“BETAโ€“HYDROXYLASEย after treatment withย BETA-blockers in hypertension.
  279. Effect of monensin on synthesis, post-translational processing, and secretion ofย DOPAMINEย BETAโ€“HYDROXYLASEย from PC12 pheochromocytoma cells.
  280. Plasma catecholamines andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in chronic renal failure
  281. Serumย DOPAMINEย BETAย HYDROXYLASEย activity and tardive dyskinesia
  282. โ€ฆ mesenteric ganglion. A. Changes in expression of transmitter-synthesizing enzymesโ€“tyrosineย HYDROXYLASEย ,ย DOPAMINEย BETAโ€“HYDROXYLASEย and choline acetyltransferase โ€ฆ
  283. Linkage analysis between manic depressive illness and theย DOPAMINEย BETAโ€“HYDROXYLASEย gene.
  284. Deglycosylated membranous and solubleย DOPAMINEย BETAโ€“HYDROXYLASEย have identical apparent molecular weights
  285. Linkage studies of catechol-O-methyltransferase (COMT) andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) cDNA expression levels
  286. Adrenal origin of the increase in plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย and catecholamines induced by hemorrhagic hypotension in dogs.
  287. Normal values for serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity.
  288. Immunohistochemical colocalization of insulin, aromatic L-amino acid decarboxylase andย DOPAMINEย BETAโ€“HYDROXYLASEย in islet B cells of chicken pancreas
  289. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) activity and blood pressure response of rat strains to shock-induced fighting
  290. Screening of Inhibitory Activity of Edible Mushrooms onย DOPAMINE
  291. Adrenal and hypothalamicย DOPAMINEโ€BETAโ€HYDROXYLASEย activity in the hamster: Evidence for speciesโ€distinctive dayโ€night and postโ€pinealectomy differences in โ€ฆ
  292. Effect of linoleic acid-rich diet on blood pressure, lipids, catecholamines, andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in spontaneously hypertensive rats.
  293. DOPAMINEย BETAโ€“HYDROXYLASEย inhibition reveals a selective influence of endotoxin on catecholamine content of rat tissues.
  294. Cerebrospinal fluid and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in human hypertension.
  295. Membraneย DOPAMINEย BETAโ€“HYDROXYLASEย : a precursor for the soluble enzyme in the bovine adrenal medulla.
  296. DOPAMINEย BETAโ€“HYDROXYLASEย and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
  297. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  298. DOPAMINEโ€“BETAโ€“HYDROXYLASEย : a modulator ofย BETAย adrenergic receptor activity.
  299. Urinary catecholamine excretion and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during mental work performed in some periods of menstrual cycle in women.
  300. Sequence tagged site (STS) TaqI RFLP atย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH).
  301. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in depression and anxiety.
  302. Effect of atropine and acetylcholine on nerve stimulated output of noradrenaline andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย from isolated rabbit and guinea pig hearts
  303. Changes in tyrosineย HYDROXYLASEย andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activities but not in phenylethanolamine-N-methyltransferase activity within central adrenaline โ€ฆ
  304. Effects of insulin-like growth factor-1 (IGF-1) receptor signaling on rates of apoptosis in retina ofย DOPAMINEย BETAย HYDROXYLASEย (Dbhโˆ’/โˆ’) knockout mice
  305. โ€ฆ performance in elderly women: significance of the 19bp insertion/deletion polymorphism in the 5โ€ฒ flank of theย DOPAMINEย BETAโ€HYDROXYLASEย gene, educational level โ€ฆ
  306. Effect ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
  307. DOPAMINEย BETAโ€“HYDROXYLASEย in human synovial fluid
  308. Effects of transgenic expression ofย DOPAMINEย BETAย HYDROXYLASEย (Dbh) gene on blood pressure in spontaneously hypertensive rats
  309. Serumย DOPAMINEย BETAย HYDROXYLASEย activity and metoclopramide provocative test in torsion dystonia
  310. Kinetic studies with competitive inhibitors indicate a sequential mechanism forย DOPAMINEย BETAโ€“HYDROXYLASEย .
  311. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and catecholamine levels in anesthetized dogs following acute hemorrhage
  312. Effects of the novelย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
  313. โ€ฆ andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย induced by forced immobilization and insulin-induced hypoglycemia: origin and fate of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  314. Contribution of adrenal medulla, spleen and lymph, to the plasma levels ofย DOPAMINEย BETAโ€“HYDROXYLASEย and catecholamines induced by hemorrhagic โ€ฆ
  315. Plasma and lymphย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and norepinephrine during carotid occlusion
  316. โ€ฆ of substituted DL-3 (5-benzazolyl) alanines as dopa and alpha-methyldopa analogs and their effects onย DOPAMINEย BETAโ€“HYDROXYLASEย , tyrosinase and diphenoloxidase.
  317. Immunofluorescent patterns of clathrin andย DOPAMINEย BETAโ€“HYDROXYLASEย in chromaffin cells in culture
  318. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in depressed patients: role of treatment.
  319. Evidence for inhibition ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in vivo after sub-acute pyrazole treatment in rats.
  320. The effects of therapy for mild hypertension on circulating level ofย DOPAMINEย BETAโ€“HYDROXYLASE
  321. Circulatingย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBETAH) and catecholamines in a paediatric phaeochromocytoma.
  322. DOPAMINEย BETAโ€“HYDROXYLASEย gene excluded in four subtypes of hereditary dystonia
  323. Co-expression of tyrosineย HYDROXYLASEย ,ย DOPAMINEย BETAโ€“HYDROXYLASEย and neuropeptide Y in the sympathetic neurons projecting to the submandibular gland in the โ€ฆ
  324. Long-term effects of propranolol on tyrosineย HYDROXYLASEย andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in the superior cervical ganglia of the rabbit [proceedings].
  325. Platelet monoamine oxidase and plasmaย DOPAMINEโ€BETAโ€HYDROXYLASEย activities in patients with multiple sclerosis
  326. Electroacupuncture analgesia is improved by adenoviral gene transfer ofย DOPAMINEย BETAโ€“HYDROXYLASEย into the hypothalamus of rats
  327. Anion-and pH-dependent activation of the soluble form ofย DOPAMINEย BETAโ€“HYDROXYLASE
  328. DOPAMINEย BETAโ€“HYDROXYLASEย inhibition: A potential therapy for the treatment of congestive heart failure
  329. Circulating pool and adrenal soluble content ofย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH), in rats, guinea pigs, dogs and humans: their role in determining acute stress โ€ฆ
  330. Immunocytochemical demonstration ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and cytochrome B561 on the axonal reticulum in bovine sympathetic neurons.
  331. Synthesis of chromogranin A,ย DOPAMINEย BETAโ€“HYDROXYLASEย , and chromaffin vesicles
  332. Evidence thatย DOPAMINEโ€BETAโ€HYDROXYLASEย immunoreactive neurons in the lateral reticular nucleus project to the spinal cord in the rat
  333. d, l-threo-3, 4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension inย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency
  334. Interactions of amphetamine, pimozide, and lithium on plasma norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in schizophrenic patients
  335. Prenatal reserpine administration: permanent changes in adrenal tyrosineย HYDROXYLASEย andย DOPAMINEย BETAโ€“HYDROXYLASEย .
  336. Subunit characterization and primary structure of bovine adrenal medullaryย DOPAMINEย BETAโ€“HYDROXYLASEย .
  337. Mechanism of inhibition ofย DOPAMINEย BETAโ€“HYDROXYLASEย evoked by FLA-63. An in vitro study.
  338. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and erythrocyte acetylcholinesterase in a group of patients with Parkinson disease
  339. Effect of electroconvulsive treatment on serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in man
  340. Central and peripheralย DOPAMINEย BETAย HYDROXYLASEย : responses to long term treatment with monoamine oxidase inhibitors
  341. Peripartum management of a patient withย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency, a rare congenital cause of dysautonomia
  342. 1-(Substituted-benzyl) imidazole-2 (3H) thione inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  343. Association betweenย DOPAMINEย BETAโ€HYDROXYLASEย polymorphism and attention function in suicide attempters with chronic schizophrenia
  344. Circulatingย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in the rat: importance of altered disposal pathways in experimental diabetes.
  345. In vitro effect of dithiocarbamate pesticides and of CaNa2EDTA on human serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  346. Effect of chronically administered nicotine on axonal transport ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in peripheral adrenergic neurons and on blood pressure and heart rate โ€ฆ
  347. Fumarate is the cause of the apparent ping-pong kinetics ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  348. DOPAMINEย BETAย HYDROXYLASEย : its relevance in the etiology of attention deficit hyperactivity disorder
  349. Inhibition by cyclopropane of release od norepinephrine, but notย DOPAMINEโ€“BETAโ€“HYDROXYLASEย , from the guinea-pig vas deferens.
  350. The effect of alpha, alpha1-dipyridyl on noradrenaline,ย DOPAMINEย and 5-hydroxytryptamine levels and onย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in brain.
  351. โ€ฆ excess and/or norepinephrine and epinephrine deficiency in autistic patients due to prenatal and/or postnatal deficiency ofย DOPAMINEย BETAโ€“HYDROXYLASE
  352. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in manic-depressive psychosis
  353. Sleeping with and without norepinephrine: effects of metoclopramide and D, L-threo-3, 4-dihydroxyphenylserine on sleep inย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency
  354. RNAi-mediated knock-down of theย DOPAMINEย BETAโ€“HYDROXYLASEย gene changes growth of razor clams
  355. Lack of correlation between serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and blood pressure in middle-aged men.
  356. Immunofluorescent and biochemical studies onย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and catecholamines in SIF cells of the superior cervical ganglion.
  357. Changes in human plasma catecholamines andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย produced by prostaglandin F2ฮฑ
  358. Immunological localization ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย on the chromaffin granule membrane
  359. Neuroleptic drug effect on plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in schizophrenia
  360. A linkage study of affective disorder with DNA markers for the ABO-AK1-ORM linkage group near theย DOPAMINEย BETAย HYDROXYLASEย gene
  361. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in the axillary bodies, the heart and the splanchnic nerve in two elasmobranchs, Squalus acanthias and Etmopterus spinax.
  362. Studies on the interaction ofย DOPAMINEย BETAโ€“HYDROXYLASEย from various sources with phytohaemagglutinins.
  363. Changes in adrenalย DOPAMINEย concentration after metyrapone or acth administration: Implications for the in vivo regulation ofย DOPAMINEย BETAโ€“HYDROXYLASEย by โ€ฆ
  364. Lโ€“arginine alleviates postmenopausal complications in female rats by stimulating ovarianย DOPAMINEย BETAย HYDROXYLASE
  365. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosedย DOPAMINEย BETAโ€“HYDROXYLASEย .
  366. Changes in the expression of tyrosineย HYDROXYLASEย (TH),ย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH), galanin (GAL), vasoactive intestinal polypeptide (VIP) and substance P โ€ฆ
  367. Epinephrine andย DOPAMINEย BETAโ€“HYDROXYLASEย secretion from bovine adrenal.
  368. Serumย DOPAMINEย BETAโ€“HYDROXYLASEย activity in acute cardiac disease
  369. 1-(Thienylalkyl) imidazole-2 (3H)-thiones as potent competitive inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  370. Endoglycosidase H susceptibility of secreted and intracellular forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  371. Evolution of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in hypo-and hyperthyroid young rats
  372. Segregation analysis ofย DOPAMINEโ€BETAโ€HYDROXYLASEย (DBH) and catecholโ€oโ€methyltransferase (COMT): Identification of major locus and polygenic components
  373. Modification of cerebrovascular CO2 reactivity by inhibition ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  374. Immunofluorescence ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in small intensely fluorescent cells of human sympathetic ganglia
  375. Retrograde axonal transport ofย DOPAMINEย BETAย HYDROXYLASEย antibodies by neurons in the trigeminal ganglion
  376. Substituted picolinic acids as DBH inhibitors. Inhibition ofย DOPAMINEย BETAโ€“HYDROXYLASEย and antihypertensive action
  377. Genetic loss of norepinephrine does not alter adult hippocampal neurogenesis inย DOPAMINEย BETAโ€“HYDROXYLASEย deficient mice
  378. RFLP for human DBH (DOPAMINEย BETAโ€“HYDROXYLASEย )
  379. โ€ฆ of bovine chromaffin granules in isotonic solutions of salts of weak organic acids. Release of catecholamines, ATP,ย DOPAMINEย BETAโ€“HYDROXYLASEย , and enkephalin-like โ€ฆ
  380. Nerve fibers showing immunoreactivities for thyrosineย HYDROXYLASEย andย DOPAMINEโ€BETAโ€HYDROXYLASEย reโ€appear in the guinea pig uvea after sympathectomy
  381. Plasmaย DOPAMINEย BETAย HYDROXYLASEย (DBH) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading
  382. Changes in serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during cold pressor test in subjects with high and low basal activity of this enzyme
  383. Lack of association betweenย DOPAMINEย BETAโ€“HYDROXYLASEย (dbh) 19-bp insertion/deletion polymorphism and risk of schizophrenia
  384. Cholinergic and GABAergic regulation ofย DOPAMINEย BETAโ€“HYDROXYLASEย activity in the adrenal gland of the rat.
  385. Plasma and tumorย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in patients with familial pheochromocytomas
  386. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and thyroid suppressibility in Gravesโ€™ disease
  387. A family study of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in schizophrenia
  388. Inhibition ofย DOPAMINEย BETAโ€“HYDROXYLASEย by 4-hydroxypyrazole: ethanol-pyrazole effects on serumย DOPAMINEย BETAโ€“HYDROXYLASEย in vivo.
  389. Circadian changes in adrenalย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity: dependency of change at darkness onset, and the effect of pinealectomy, on animal strain and age.
  390. An Electron Microscopic Immunocytochemical Study on the Tyrosineย HYDROXYLASEย โ€Positive,ย DOPAMINEย BETAโ€HYDROXYLASEย โ€Negative Cells in the Pineal Gland of โ€ฆ
  391. Molecular forms ofย DOPAMINEย BETAโ€“HYDROXYLASEย in rat superior cervical ganglion and adrenal gland
  392. Changes in plasmaย DOPAMINEย BETAโ€HYDROXYLASEย activity induced by stimulation of the complete sympathetic outflow in the pithed rat.
  393. The influence ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors on avoidance reaction in rat.
  394. Effects of prolonged disulfiram treatment on plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in rhesus monkeys.
  395. Noradrenaline andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย levels in rat salivary glands after preganglionic nerve stimulation: Evidence for re-use of amine storage granules in โ€ฆ
  396. Alterations in plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and catecholamine concentrations during surgical removal of pheochromocytoma.
  397. Development ofย DOPAMINEโ€BETAโ€HYDROXYLASEย โ€”positive fiber innervation in coโ€cultured hippocampusโ€locus coeruleus organotypic slices
  398. Lithium: effects of short-term and chronic treatments in rats on the activity ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) in the central versus peripheral nervous system
  399. Synthesis of several 2-substituted 3-(p-hydroxyphenyl)-1-propenes and their characterization as mechanism-based inhibitors ofย DOPAMINEย BETAโ€“HYDROXYLASEย .
  400. Mechanism-based inhibition ofย DOPAMINE-.ย BETA.-HYDROXYLASE
  401. From gene to disease;ย DOPAMINEโ€“BETAโ€“HYDROXYLASEย deficiency and orthostatic hypotension
  402. Congenitalย DOPAMINEย BETAโ€“HYDROXYLASEย deficiency
  403. Cerebrospinal fluid norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in affective illness and schizophrenia
  404. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in a new strain of spontaneously hypertensive rats
  405. Mechanistic and Structural Studies ofย DOPAMINEย BETAโ€“HYDROXYLASE
  406. Effects of short-term lithium treatment in rats on the activity ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in various brain regions.
  407. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in serum of patients with hepatic damage.
  408. Construction of Nursing Intervention Model and Clinical Empirical Study onย DOPAMINEย BETAย HYDROXYLASEย Gene Polymorphism in Children with ADHD
  409. Benzofurans as mechanism-based inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  410. Effects of phenyl-2-aminoethyl sulfide, a novelย DOPAMINEโ€“BETAโ€“HYDROXYLASEย substrate, on the cardiovascular system of the anesthetized dog.
  411. Effect ofย BETA-adrenergic blockade on plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and triiodothyronine in hyperthyroidism
  412. Measurements of noradrenaline overflow andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in superfused preparations [proceedings]
  413. Catecholamineโ€containing,ย DOPAMINEโ€BETAโ€HYDROXYLASEย โ€immunoreactive perivascular nerve specializations in the rat kidney
  414. Changes in serumย DOPAMINEย BETAย HYDROXYLASEย activity related to coma.
  415. Pharmacological action of FD-008, a newย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitor. III. Effects on endogenous biogenic amine levels in rats.
  416. DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) AND PUPILLARY SYMPATHETIC ACTIVITY IN IDIOPATHIC TORSION DYSTONIA (ITD)
  417. Plasma noradrenalin andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย during behavioral testing of sexually deviant XYY and XXY males
  418. Relationship betweenย DOPAMINEโ€“BETAโ€“HYDROXYLASEย gene polymorphism and hypertensive disorder complicating pregnancy
  419. Synthesis of 6-alkylaminopyridazine-3-carboxylic acid derivatives asย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitors
  420. Metabolic clearance rate ofย DOPAMINEย BETAโ€“HYDROXYLASEย in the rat.
  421. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in adrenal gland and spleen of rats after fasting and cold exposure
  422. Modification of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity by adrenal and pineal extirpations, and time of day dependency of changes.
  423. DOPAMINEย BETAโ€HYDROXYLASEย activity in cerebrospinal fluid of idiopathic torsion dystonia
  424. Effect of butobendin onย DOPAMINEย BETAโ€“HYDROXYLASEย in vitro.
  425. DOPAMINEย BETAย HYDROXYLASEย . Value and limits of its study in neurology
  426. Effect ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol โ€ฆ
  427. DOPAMINEโ€“BETAโ€“HYDROXYLASEย effectors in neuroblastoma
  428. Comparison of physico-chemical properties of two forms ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย from chromaffin granules
  429. Proceedings: The mechanism of the effect ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
  430. Responses of plasma renin activity andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย to increased intravascular volume
  431. Low serumย DOPAMINEโ€”BETAโ€“HYDROXYLASEย activity in patients with panic disorder
  432. Antiarrhythmic efficiency of Craviten and changes in the activities of serumย DOPAMINEย BETAโ€“HYDROXYLASEย and erythrocyte membrane ATPases.
  433. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity after acute myocardial infarction.
  434. Control of Synthesis, Transport and Release ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and Tyrosineย HYDROXYLASE
  435. DOPAMINEย BETAโ€“HYDROXYLASEย activity in cerebrospinal fluid of hydrocephalic patients
  436. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in spasmodic torticollis
  437. Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in fasting man.
  438. Anion activation ofย DOPAMINEย BETAโ€“HYDROXYLASEย : a kinetic model.
  439. Structural and kinetic studies of bovineย DOPAMINEย BETAโ€“HYDROXYLASE
  440. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in neuroblastoma.
  441. Effects of Herbal Drugs on Bovine Adrenal Tyrosineย HYDROXYLASEย andย DOPAMINEย (II)
  442. Structural study ofย DOPAMINEย BETAย HYDROXYLASEย purified from human serum
  443. Biosynthesis, glycosylation and cellular sorting of humanย DOPAMINEย BETAโ€“HYDROXYLASEย .
  444. Plasma catecholamine concentration andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during haemodialysis with acetate or bicarbonate at different sodium concentrations in โ€ฆ
  445. Developmental pattern ofย DOPAMINEย BETAโ€“HYDROXYLASEย induction in the adrenals of the rat. Influence of neonatal hypothyroidism.
  446. Studies on the stability of an enzyme-inhibitor complex using a mechanism-based inhibitor ofย DOPAMINE.ย BETA.-HYDROXYLASE
  447. Sympathoadrenal activity and plasma glucose effects on plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย levels in rats
  448. Lymphocyteย BETA-adrenoreceptor function in congestive heart failure: modulation byย DOPAMINEโ€“BETAโ€“HYDROXYLASE
  449. Interaction of central neurotransmitters in the regulation of adrenalย DOPAMINEย BETAโ€“HYDROXYLASE
  450. Changes in plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in patients with acute subarachnoid hemorrhage (authorโ€™s transl)
  451. Preparations of humanย DOPAMINEย BETAย HYDROXYLASEย subunits and antibodies against these subunits (authorโ€™s transl)
  452. Using plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย activity and its interrelations with bioelement content to predict depression in the rat model
  453. Clinical and Functional Implications of the Arg549Cys (rs6271) Polymorphism inย DOPAMINEย BETAโ€“HYDROXYLASE
  454. Brainย DOPAMINEย BETAย HYDROXYLASEย Activity In Vivo: Pharmacological, Endocrinological, and Psychological Implications for Adaptation
  455. Regulation of the translation and processing of ratย DOPAMINEย BETAโ€“HYDROXYLASEย by metal ions in a cell free system.
  456. Plasmaย DOPAMINEย BETAย HYDROXYLASEย activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
  457. Implication of cerebralย DOPAMINEโ€“BETAย HYDROXYLASEย for cardiovascular and mood regulation in rats
  458. The stimulated release ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย from intact organs of normo-and hypertensive rats [proceedings].
  459. Co-expression pattern ofย DOPAMINEย BETAโ€“HYDROXYLASEย (DฮฒH) and neuropeptide Y (NPY) within sympathetic innervation of ovary and umbilical cord of the European โ€ฆ
  460. DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
  461. DYNAMICS OF PLASMA AND LYMPHย DOPAMINEโ€“BETAโ€“HYDROXYLASEย AS RELATED TO SYMPATHETIC NERVOUS SYSTEM ACTIVITY.
  462. Serumย DOPAMINEย BETAย HYDROXYLASEย (DฮฒH) enzyme activity changes within individual women according to stage of pregnancy: Evidence that regulation of expression โ€ฆ
  463. The effects of someย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors on the control mechanisms of the estrous cycle in rats.
  464. Alteration of bloodย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in patients with intrahepatic portal hypertension
  465. An Association Study between Four Polymorphisms in theย DOPAMINEย BETAโ€“HYDROXYLASEย Gene and Schizophrenia in Korean Population
  466. Catecholamines and theย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms
  467. Activity of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and urine excretion of catecholamines in patients with deficiency-cold and deficiency-heat syndromes
  468. The 444G/A and-1021 C/T polymorphisms of theย DOPAMINEโ€“BETAโ€“HYDROXYLASEย gene modulate the trajectory of alcohol dependence development
  469. A family-based and case-control association study of theย DOPAMINEย BETAย HYDROXYLASEย gene polymorphism in attention deficit hyperactivity disorder
  470. DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors, feeding and locomotir activity: Reinstatement of feeding following central norepinephrine
  471. Effect of substance P onย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and phenethanolamine-N-methyltransferase in the adrenal glands of rats
  472. The Role of theย DOPAMINEย BETAโ€“HYDROXYLASEย Functional Polymorphism in Patients with Early-Onset Parkinsonโ€™s Disease in the Turkish Population
  473. Noradrenergic innervation of rat neocortex during development: immunocytochemical evidence using anti-DOPAMINEโ€“BETAโ€“HYDROXYLASEย antibodies
  474. Ontogeny of epinephrine, norepinephrine,ย DOPAMINEโ€“BETAโ€“HYDROXYLASEย , and chromogranin A in the adrenal gland of pigs.
  475. Proceedings: Effect ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitors and centrally administered noradrenaline on (+)-amphetamine anorexia in mice.
  476. The activity of monoamine oxidase in the interscapular brown adipose tissue andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in the serum depends on the rat thyroid status
  477. Deglycosylation ofย DOPAMINE.ย BETA.-HYDROXYLASE
  478. Subclassification of hyperactive children on the basis of minor physical anomalies and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity: An attempted replication
  479. Asymmetrical content ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and phenylethanolamine-N-methyltransferase in the adrenals of spontaneously hypertensive and normotensive โ€ฆ
  480. Effects ofย DOPAMINEย BETAย HYDROXYLASEย Levels in a Mouse Model of FD
  481. STRUCTURAL STUDIES OFย DOPAMINEย BETAโ€“HYDROXYLASE
  482. Hydrazines as inhibitors ofย DOPAMINE.ย BETA.-HYDROXYLASE
  483. Role ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inย DOPAMINEย metabolism in the heart
  484. MECHANISM-BASED INHIBITION OFย DOPAMINEย BETAโ€“HYDROXYLASE
  485. Kinetic properties of membraneย DOPAMINEโ€“BETAโ€“HYDROXYLASEย .
  486. โ€ฆ ) antidepressants? Despite the ability of the major metabolite of disulfiram (diethyldithiocarbamate) to inhibit the enzymeย DOPAMINEย BETAโ€“HYDROXYLASEย and a report of โ€ฆ
  487. DOPAMINEย BETAโ€“HYDROXYLASEย activity after subarachnoid hemorrhage
  488. DOPAMINEโ€“BETAโ€“HYDROXYLASEย in patients with cystic fibrosis
  489. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity during labour in women.
  490. KINETIC STUDIES ON THE MECHANISMS OF TYROSINEย HYDROXYLASEย ANDย DOPAMINEย BETAโ€“HYDROXYLASE
  491. DOPAMINEย BETAโ€“HYDROXYLASEย Deficiency GeneReviewโ€“Diagnosis: Additional Tests/Findings
  492. Ophthalmic Findings in Patients withย DOPAMINEย BETAโ€“HYDROXYLASEย Deficiency
  493. STRUCTURAL ANALYSIS OF THE SOLUBLE FORM OF BOVINEย DOPAMINEย BETAโ€“HYDROXYLASE
  494. DOPAMINEโ€“BETAโ€“HYDROXYLASEย : NOVEL SUBSTRATES, INHIBITORS AND MECHANISTIC STUDIES.
  495. Plasmaย DOPAMINEย BETAโ€“HYDROXYLASEย activity in clinically healthy children
  496. Screening ofย DOPAMINEย inhibitory activity from various wild plants
  497. Biolchemical mechanism of the toxicity of dithiocarbamate series fungicides: The inhibitory action onย DOPAMINEย BETAโ€“HYDROXYLASEย activity.
  498. โ€ฆ MONOSODIUM GLUTAMATE ON BRAIN TYROSINEย HYDROXYLASEย ,ย DOPAMINEโ€”HYDROXYLASEย , TRYPTOPHANย HYDROXYLASEย AND MONOAMINE OXIDSE โ€ฆ
  499. The regulation of alpha-synuclein on tyrosineย HYDROXYLASEย orย DOPAMINEย BETAย HYDROXYLASE
  500. ISOLATION AND STRUCTURAL COMPARISONS OF SOLUBLE AND MEMBRANE-BOUNDย DOPAMINEโ€“BETAโ€“HYDROXYLASEย PROTEINS FROM HUMAN AND โ€ฆ
  501. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย as an index of peripheral noradrenergic activity
  502. Etamicastat, a newย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitor: Pharmacological characterization
  503. Determination ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in human placenta at early stage
  504. PLASMAย DOPAMINEโ€“BETAโ€“HYDROXYLASEย ACTIVITY IN TOURETTEโ€™S DISORDER AND CHRONIC MOTOR TIC DISORDER
  505. DOPAMINEย BETAโ€“HYDROXYLASEย andย BETAย 2-microglobulin in cerebrospinal fluid: early markers in Parkinsonโ€™s disease?
  506. A Study on Serumย DOPAMINEโ€”HYDROXYLASEย Activity and Thermostability in a Randomly Selected Population of Adults
  507. Correlation between theย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity and the level of plasma catecholamines during muscular exercise
  508. Effect of zamicastat, aย DOPAMINEย BETAโ€“HYDROXYLASEย inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension
  509. Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) activity in two kinds of acute stress in rabbits.
  510. Determination of the adrenergic response by measurement of catecholamines and activity ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (D-BETA-B) in arterial capillary blood
  511. STRUCTURAL AND ENZYMATIC STUDIES OFย DOPAMINEโ€“BETAโ€“HYDROXYLASEย FROM BOVINE ADRENAL CHROMAFFIN GRANULES.
  512. Activity of plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย in newborn infants. Implication in prematurity, maternal pathology and growth
  513. THE CORRELATION BETWEEN ONTOGENESIS OF PLASMA $ย DOPAMINE-{\BETA}-HYDROXYLASEย $ ACTIVITY AND PSYCHOPATHOLOGY IN INFANTILE AUTISM
  514. Investigation of acquired hearing loss inย DOPAMINEย BETAย HYDROXYLASEย (DBH)-mutant mice
  515. Varied mechanisms of estradiol mediated regulation ofย DOPAMINEย BETAโ€HYDROXYLASEย (DBH) gene transcription
  516. DOPAMINEย BETAโ€“HYDROXYLASEย activity and its interrelations with bioelements in serum of rats after electroconvulsive shock therapy
  517. Acupuncture Improves Withdrawal Symptoms by Inhibiting Tyrosineย HYDROXYLASEย andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย Expression in the Midbrain of Heroin Re-addicted โ€ฆ
  518. CEREBROSPINAL FLUID NOREPINEPHRINE ANDย DOPAMINEโ€“BETAโ€“HYDROXYLASEย IN AFFECTIVE ILLNESS AND SCHIZOPHRENIA
  519. Polymorphisms of theย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) gene show associations with cognitive flexibility in mentally healthy adults
  520. Differences in the retrograde axonal transport of nerve growth factor andย DOPAMINEย BETAโ€HYDROXYLASE
  521. Targeting of sympathetic neurons in vivo with an anti-DOPAMINEย BETAโ€“HYDROXYLASEย immunotoxin.
  522. Relationship Between Electroencephalographic (EEG) Synchronization and Plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย (DBH) Activity in Patients
  523. The effect of one-time and repeated starvation onย DOPAMINEย BETAโ€“HYDROXYLASEย serum activity in rats of various ages
  524. Pharmacological inhibition ofย DOPAMINEย BETAโ€HYDROXYLASEย blocks cocaineโ€induced reinstatement in rats
  525. Electron transfer toย DOPAMINEย BETAโ€“HYDROXYLASEย in chromaffin granule membranes.
  526. Changes in human plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity after ketamine and halothane anesthesia.
  527. Changes ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and activator protein-2 expression in spinal cord of formalin-induced rat pain model
  528. Synthesis of potential inhibitors ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย : Heterocyclic analogues and sulfur-containing derivatives ofย BETA-phenethylamines
  529. An Epidemiological Study of the Relationship between Serumย DOPAMINEโ€“BETAโ€“HYDROXYLASEย Activity and Urinary Noradrenaline, and Their Relationship to Blood โ€ฆ
  530. Platelet mono amine oxidase and plasmaย DOPAMINEย BETAย HYDROXYLASEย activity in patients with Schizophrenia
  531. Synthesis of carbonโ€14 and tritium labeledย DOPAMINEย BETAโ€HYDROXYLASEย inhibitors of the imidazolinethione type
  532. Changes ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and activator protein-2? expression in spinal cord of formalin-induced rat pain model
  533. Screening of Vegetables for Inhibition Activity onย DOPAMINEย โ€“HYDROXYLASEย (DBH) and Monoamine oxidase (MAO)
  534. Proceedings: Reduction of locomotor activity in mice byย DOPAMINEโ€“BETAโ€“HYDROXYLASEย inhibitorsโ€“evidence against the involvement of non-specific irritation.
  535. Regulatory mechanisms ofย DOPAMINEย BETAโ€“HYDROXYLASEย gene expression: Noradrenergic neuron-specific gene regulation
  536. Tyrosineย HYDROXYLASEย ,ย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and Phenylethanolamine-N-Methyltransferase Immunoreactive Neurons of the Medulla Oblongata in the โ€ฆ
  537. Effects ofย DOPAMINEย BETAโ€HYDROXYLASEย (DBH) inhibition on cocaineโ€induced reinstatement in squirrel monkeys
  538. Synthesis of 5-(substituted alkyl) picolinic acids, theย DOPAMINE.ย BETA.-HYDROXYLASEย inhibitors. I.
  539. Distribution ofย DOPAMINEโ€“BETAย HYDROXYLASEย (DBH) immunoreactivity in male zebra finch brains: Effects of hormone and DSP-4 treatments
  540. Muscarinic regulation of the stimulated release of norepinephrine andย DOPAMINEโ€“BETAโ€“HYDROXYLASEย from sympathetic nerves to the heart.
  541. COMPARISONS OF PURIFIEDย DOPAMINEโ€“BETAโ€“HYDROXYLASEย FROM BOVINE LARGE DENSE CORED NORADRENERGIC VESICLES AND โ€ฆ
  542. Genetics of autism: the maternal genotype at theย DOPAMINEย BETAย HYDROXYLASEย locus may be a factor in the etiology of autism and related pervasive developmental โ€ฆ
  543. Total Kininogen Levels, Plasma Renin Activity,ย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and Plasma Catecholamines in Chronic and Acute Renal Failure
  544. Alterations inย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) activity, TAS (Total Antioxidative Status), Mg and Zn contents in human serum after Zn supplementation
  545. DOPAMINEย BETAโ€“HYDROXYLASEย : STRUCTURAL AND KINETIC STUDIES ON THE SOLUBLE AND MEMBRANOUS FORMS OF ENZYME FROM BOVINE โ€ฆ
  546. โ€ฆ T, Blazekovic A, Perkovic MN, Jercic KG, Sustar A, Smircic-Duvnjak L, Outeiro TF, Pivac N, Borovecki F. The influence ofย DOPAMINEโ€“BETAโ€“HYDROXYLASEย and catechol O โ€ฆ
  547. โ€ฆ biological activity using an allogeneic intervertebral disc supplemented with transfected nucleus pulposus cells expressing exogenousย DOPAMINEย BETAโ€“HYDROXYLASEย .
  548. Selective Ablation ofย DOPAMINEย BETAโ€“HYDROXYLASEย Neurons (Subpopulation of TH Neurons) in the Brain: New Insights into Brain Catecholaminergic Circuitry and โ€ฆ
  549. Comparative studies of urinary electrolyte excretion, the renin-angiotensin-aldosterone system and plasmaย DOPAMINEโ€“BETAโ€“HYDROXYLASEย activity in patients with โ€ฆ
  550. โ€ฆ ADRENAL CHROMAFFIN GRANULE MEMBRANES FOLLOWING SECRETION (VESICLE, EXOCYTOSIS, CATECHOLAMINE,ย DOPAMINEโ€“BETAโ€“HYDROXYLASEย โ€ฆ
  551. Activity of the adrenergic nervous system in the pathophysiology of pregnancy and labor. I.ย DOPAMINEย BETAโ€“HYDROXYLASEย (DBH) activity in the plasma of women with โ€ฆ
  552. โ€ฆ monocytogenes and Mycobacterium tuberculosis-dendritic cells as an โ€œAchillesโ€™ Heelโ€ and immune deficiency inย DOPAMINEย BETAโ€“HYDROXYLASEย knock-out mice
  553. Syntheses and enzymatic studies of novel substrate analogs of phenylalanineย HYDROXYLASEย andย DOPAMINEย BETAย monooxygenase

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop